Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1987 Mar;84(5):1425–1428. doi: 10.1073/pnas.84.5.1425

Peroxisomal beta-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked adrenoleukodystrophy and neonatal adrenoleukodystrophy.

W W Chen, P A Watkins, T Osumi, T Hashimoto, H W Moser
PMCID: PMC304443  PMID: 3469675

Abstract

Very long chain fatty acids, which accumulate in plasma and tissues in X-linked adrenoleukodystrophy (ALD), neonatal ALD, and the Zellweger cerebrohepatorenal syndrome, are degraded by the peroxisomal beta-oxidation pathway, consisting of acyl-CoA oxidase, the bifunctional enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase, and beta-ketothiolase. A marked deficiency of all three enzyme proteins was reported in livers from patients with the Zellweger syndrome, a disorder in which peroxisomes are decreased or absent. Peroxisomes are not as markedly decreased in neonatal ALD and appear normal in X-linked ALD. Immunoblot analysis of the peroxisomal beta-oxidation enzymes revealed an almost complete lack of the bifunctional enzyme in neonatal ALD liver, similar to the finding in Zellweger tissue. In contrast, acyl-CoA oxidase and beta-ketothiolase were present in neonatal ALD liver, although the thiolase appeared to be in precursor form (2-3 kDa larger than the mature enzyme) in neonatal ALD. Unlike either neonatal ALD or Zellweger syndrome, all three peroxisomal beta-oxidation enzymes were present in X-linked ALD liver. Despite the absence in neonatal ALD liver of bifunctional enzyme protein, its mRNA was detected by RNA blot analysis in fibroblasts from these patients. These observations suggest that lack of bifunctional enzyme protein in neonatal ALD results from either abnormal translation of the mRNA or degradation of the enzyme prior to its entry into peroxisomes.

Full text

PDF
1425

Images in this article

1426Image
on p.1426
1426Image
on p.1426
1426Image
on p.1426
1426Image
on p.1426
1426Image
on p.1426
1426Image
on p.1426
1427Image
on p.1427
1427Image
on p.1427
1427Image
on p.1427
1427Image
on p.1427
1427Image
on p.1427
1427Image
on p.1427
1427Image
on p.1427
1427Image
on p.1427
1427Image
on p.1427
1427Image
on p.1427
1427Image
on p.1427
1427Image
on p.1427
1427Image
on p.1427

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballas L. M., Lazarow P. B., Bell R. M. Glycerolipid synthetic capacity of rat liver peroxisomes. Biochim Biophys Acta. 1984 Sep 12;795(2):297–300. doi: 10.1016/0005-2760(84)90079-1. [DOI] [PubMed] [Google Scholar]
  2. Brown F. R., 3rd, McAdams A. J., Cummins J. W., Konkol R., Singh I., Moser A. B., Moser H. W. Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids. Johns Hopkins Med J. 1982 Dec;151(6):344–351. [PubMed] [Google Scholar]
  3. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  4. Danks D. M., Tippett P., Adams C., Campbell P. Cerebro-hepato-renal syndrome of Zellweger. A report of eight cases with comments upon the incidence, the liver lesion, and a fault in pipecolic acid metabolism. J Pediatr. 1975 Mar;86(3):382–387. doi: 10.1016/s0022-3476(75)80967-x. [DOI] [PubMed] [Google Scholar]
  5. Datta N. S., Wilson G. N., Hajra A. K. Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome. A new category of metabolic disease involving the absence of peroxisomes. N Engl J Med. 1984 Oct 25;311(17):1080–1083. doi: 10.1056/NEJM198410253111704. [DOI] [PubMed] [Google Scholar]
  6. De Duve C., Baudhuin P. Peroxisomes (microbodies and related particles). Physiol Rev. 1966 Apr;46(2):323–357. doi: 10.1152/physrev.1966.46.2.323. [DOI] [PubMed] [Google Scholar]
  7. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  8. Fujiki Y., Rachubinski R. A., Mortensen R. M., Lazarow P. B. Synthesis of 3-ketoacyl-CoA thiolase of rat liver peroxisomes on free polyribosomes as a larger precursor. Induction of thiolase mRNA activity by clofibrate. Biochem J. 1985 Mar 15;226(3):697–704. doi: 10.1042/bj2260697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Furuta S., Miyazawa S., Osumi T., Hashimoto T., Ui N. Properties of mitochondria and peroxisomal enoyl-CoA hydratases from rat liver. J Biochem. 1980 Oct;88(4):1059–1070. doi: 10.1093/oxfordjournals.jbchem.a133057. [DOI] [PubMed] [Google Scholar]
  10. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goldfischer S., Collins J., Rapin I., Coltoff-Schiller B., Chang C. H., Nigro M., Black V. H., Javitt N. B., Moser H. W., Lazarow P. B. Peroxisomal defects in neonatal-onset and X-linked adrenoleukodystrophies. Science. 1985 Jan 4;227(4682):67–70. doi: 10.1126/science.3964959. [DOI] [PubMed] [Google Scholar]
  12. Goldfischer S., Moore C. L., Johnson A. B., Spiro A. J., Valsamis M. P., Wisniewski H. K., Ritch R. H., Norton W. T., Rapin I., Gartner L. M. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science. 1973 Oct 5;182(4107):62–64. doi: 10.1126/science.182.4107.62. [DOI] [PubMed] [Google Scholar]
  13. Goldfischer S., Powers J. M., Johnson A. B., Axe S., Brown F. R., Moser H. W. Striated adrenocortical cells in cerebro-hepato-renal (Zellweger) syndrome. Virchows Arch A Pathol Anat Histopathol. 1983;401(3):355–361. doi: 10.1007/BF00734851. [DOI] [PubMed] [Google Scholar]
  14. Govaerts L., Monnens L., Tegelaers W., Trijbels F., van Raay-Selten A. Cerebro-hepato-renal syndrome of Zellweger: clinical symptoms and relevant laboratory findings in 16 patients. Eur J Pediatr. 1982 Oct;139(2):125–128. doi: 10.1007/BF00441495. [DOI] [PubMed] [Google Scholar]
  15. Hajra A. K., Bishop J. E. Glycerolipid biosynthesis in peroxisomes via the acyl dihydroxyacetone phosphate pathway. Ann N Y Acad Sci. 1982;386:170–182. doi: 10.1111/j.1749-6632.1982.tb21415.x. [DOI] [PubMed] [Google Scholar]
  16. Hanson R. F., Szczepanik-VanLeeuwen P., Williams G. C., Grabowski G., Sharp H. L. Defects of bile acid synthesis in Zellweger's syndrome. Science. 1979 Mar 16;203(4385):1107–1108. doi: 10.1126/science.424737. [DOI] [PubMed] [Google Scholar]
  17. Heymans H. S., Schutgens R. B., Tan R., van den Bosch H., Borst P. Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome). Nature. 1983 Nov 3;306(5938):69–70. doi: 10.1038/306069a0. [DOI] [PubMed] [Google Scholar]
  18. Johnson A. B., Schaumburg H. H., Powers J. M. Histochemical characteristics of the striated inclusions of adrenoleukodystrophy. J Histochem Cytochem. 1976 Jun;24(6):725–730. doi: 10.1177/24.6.59773. [DOI] [PubMed] [Google Scholar]
  19. Kase F., Björkhem I., Pedersen J. I. Formation of cholic acid from 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid by rat liver peroxisomes. J Lipid Res. 1983 Dec;24(12):1560–1567. [PubMed] [Google Scholar]
  20. Kelley R. I., Datta N. S., Dobyns W. B., Hajra A. K., Moser A. B., Noetzel M. J., Zackai E. H., Moser H. W. Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes. Am J Med Genet. 1986 Apr;23(4):869–901. doi: 10.1002/ajmg.1320230404. [DOI] [PubMed] [Google Scholar]
  21. Kelley R. I., Moser H. W. Hyperpipecolic acidemia in neonatal adrenoleukodystrophy. Am J Med Genet. 1984 Dec;19(4):791–795. doi: 10.1002/ajmg.1320190420. [DOI] [PubMed] [Google Scholar]
  22. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  23. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  24. Lazarow P. B., De Duve C. A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci U S A. 1976 Jun;73(6):2043–2046. doi: 10.1073/pnas.73.6.2043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lazarow P. B. Rat liver peroxisomes catalyze the beta oxidation of fatty acids. J Biol Chem. 1978 Mar 10;253(5):1522–1528. [PubMed] [Google Scholar]
  26. Mathis R. K., Watkins J. B., Szczepanik-Van Leeuwen P., Lott I. T. Liver in the cerebro-hepato-renal syndrome: defective bile acid synthesis and abnormal mitochondria. Gastroenterology. 1980 Dec;79(6):1311–1317. [PubMed] [Google Scholar]
  27. Miura S., Mori M., Takiguchi M., Tatibana M., Furuta S., Miyazawa S., Hashimoto T. Biosynthesis and intracellular transport of enzymes of peroxisomal beta-oxidation. J Biol Chem. 1984 May 25;259(10):6397–6402. [PubMed] [Google Scholar]
  28. Miyazawa S., Osumi T., Hashimoto T. The presence of a new 3-oxoacyl-CoA thiolase in rat liver peroxisomes. Eur J Biochem. 1980 Feb;103(3):589–596. doi: 10.1111/j.1432-1033.1980.tb05984.x. [DOI] [PubMed] [Google Scholar]
  29. Mooi W. J., Dingemans K. P., van den Bergh Weerman M. A., Jöbsis A. C., Heymans H. S., Barth P. G. Ultrastructure of the liver in th cerebrohepatorenal syndrome of Zellweger. Ultrastruct Pathol. 1983 Sep-Oct;5(2-3):135–144. doi: 10.3109/01913128309141833. [DOI] [PubMed] [Google Scholar]
  30. Moser A. E., Singh I., Brown F. R., 3rd, Solish G. I., Kelley R. I., Benke P. J., Moser H. W. The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis. N Engl J Med. 1984 May 3;310(18):1141–1146. doi: 10.1056/NEJM198405033101802. [DOI] [PubMed] [Google Scholar]
  31. Moser H. W., Moser A. E., Singh I., O'Neill B. P. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy. Ann Neurol. 1984 Dec;16(6):628–641. doi: 10.1002/ana.410160603. [DOI] [PubMed] [Google Scholar]
  32. Osumi T., Hashimoto T. Acyl-CoA oxidase of rat liver: a new enzyme for fatty acid oxidation. Biochem Biophys Res Commun. 1978 Jul 28;83(2):479–485. doi: 10.1016/0006-291x(78)91015-x. [DOI] [PubMed] [Google Scholar]
  33. Osumi T., Hashimoto T. Occurrence of two 3-hydroxyacyl-CoA dehydrogenases in rat liver. Biochim Biophys Acta. 1979 Aug 30;574(2):258–267. [PubMed] [Google Scholar]
  34. Osumi T., Hashimoto T., Ui N. Purification and properties of acyl-CoA oxidase from rat liver. J Biochem. 1980 Jun;87(6):1735–1746. doi: 10.1093/oxfordjournals.jbchem.a132918. [DOI] [PubMed] [Google Scholar]
  35. Osumi T., Ishii N., Hijikata M., Kamijo K., Ozasa H., Furuta S., Miyazawa S., Kondo K., Inoue K., Kagamiyama H. Molecular cloning and nucleotide sequence of the cDNA for rat peroxisomal enoyl-CoA: hydratase-3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme. J Biol Chem. 1985 Jul 25;260(15):8905–8910. [PubMed] [Google Scholar]
  36. Parmentier G. G., Janssen G. A., Eggermont E. A., Eyssen H. J. C27 bile acids in infants with coprostanic acidemia and occurrence of a 3 alpha,7 alpha,12 alpha-tridhydroxy-5 beta-C29 dicarboxylic bile acid as a major component in their serum. Eur J Biochem. 1979 Dec;102(1):173–183. doi: 10.1111/j.1432-1033.1979.tb06278.x. [DOI] [PubMed] [Google Scholar]
  37. Pedersen J. I., Gustafsson J. Conversion of 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid into cholic acid by rat liver peroxisomes. FEBS Lett. 1980 Dec 1;121(2):345–348. doi: 10.1016/0014-5793(80)80377-2. [DOI] [PubMed] [Google Scholar]
  38. Powers J. M., Schaumberg H. H. Adreno-leukodystrophy. Similar ultrastructural changes in adrenal cortical and Schwann cells. Arch Neurol. 1974 May;30(5):406–408. doi: 10.1001/archneur.1974.00490350064011. [DOI] [PubMed] [Google Scholar]
  39. Rachubinski R. A., Fujiki Y., Mortensen R. M., Lazarow P. B. Acyl-Coa oxidase and hydratase-dehydrogenase, two enzymes of the peroxisomal beta-oxidation system, are synthesized on free polysomes of clofibrate-treated rat liver. J Cell Biol. 1984 Dec;99(6):2241–2246. doi: 10.1083/jcb.99.6.2241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Schaumburg H. H., Powers J. M., Raine C. S., Suzuki K., Richardson E. P., Jr Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol. 1975 Sep;32(9):577–591. doi: 10.1001/archneur.1975.00490510033001. [DOI] [PubMed] [Google Scholar]
  41. Schaumburg H. H., Powers J. M., Suzuki K., Raine C. S. Adreno-leukodystrophy (sex-linked Schilder disease). Ultrastructural demonstration of specific cytoplasmic inclusions in the central nervous system. Arch Neurol. 1974 Sep;31(3):210–213. doi: 10.1001/archneur.1974.00490390092013. [DOI] [PubMed] [Google Scholar]
  42. Singh I., Moser A. E., Goldfischer S., Moser H. W. Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc Natl Acad Sci U S A. 1984 Jul;81(13):4203–4207. doi: 10.1073/pnas.81.13.4203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Singh I., Moser A. E., Moser H. W., Kishimoto Y. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes. Pediatr Res. 1984 Mar;18(3):286–290. doi: 10.1203/00006450-198403000-00016. [DOI] [PubMed] [Google Scholar]
  44. Singh I., Moser H. W., Moser A. B., Kishimoto Y. Adrenoleukodystrophy: impaired oxidation of long chain fatty acids in cultured skin fibroblasts an adrenal cortex. Biochem Biophys Res Commun. 1981 Oct 30;102(4):1223–1229. doi: 10.1016/s0006-291x(81)80142-8. [DOI] [PubMed] [Google Scholar]
  45. Tager J. M., Van der Beek W. A., Wanders R. J., Hashimoto T., Heymans H. S., Van den Bosch H., Schutgens R. B., Schram A. W. Peroxisomal beta-oxidation enzyme proteins in the Zellweger syndrome. Biochem Biophys Res Commun. 1985 Feb 15;126(3):1269–1275. doi: 10.1016/0006-291x(85)90322-5. [DOI] [PubMed] [Google Scholar]
  46. Thomas P. S. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5201–5205. doi: 10.1073/pnas.77.9.5201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Tolbert N. E. Metabolic pathways in peroxisomes and glyoxysomes. Annu Rev Biochem. 1981;50:133–157. doi: 10.1146/annurev.bi.50.070181.001025. [DOI] [PubMed] [Google Scholar]
  48. de Duve C. The peroxisome: a new cytoplasmic organelle. Proc R Soc Lond B Biol Sci. 1969 Apr 15;173(1030):71–83. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES